Shinichiro Sumi

Title: Innovator Shinichiro Sumi: Advancing Human Urogastrone Technology

Introduction: Shinichiro Sumi is a notable inventor based in Hiroshima, Japan. He has made significant contributions to biotechnology, particularly through his innovative work on human urogastrone.

Latest Patents: Sumi holds a patent for [21-leucine] human urogastrone. This invention involves a polypeptide characterized by a specific amino acid sequence, which has shown to be equivalent to the existing human urogastrone that features 21-Met. His patent also encompasses the synthesis of this compound, which includes double-stranded polydeoxyribonucleotides with a structural gene for hUG expression, a recombinant plasmid for the same, and genetically engineered E. coli transformed by this plasmid. The substitution of Methionine with Leucine allows for a more efficient production method of the hUG peptide.

Career Highlights: Sumi's inventive journey has been marked by his position at Wakunaga Seiyaku Kabushiki Kaisha, a leading company in the field of biotechnology. His work focuses on enhancing the methods for producing human urogastrone, aiming to improve its applications in medicine.

Collaborations: Throughout his career, Shinichiro Sumi has collaborated with talented coworkers such as Kenichi Miyoshi and Akira Hasegawa. Together, they have worked on groundbreaking projects that push the boundaries of biotechnology and genetic engineering.

Conclusion: Shinichiro Sumi’s inventive efforts in the field of human urogastrone are leading to promising advancements in medical technology. His patent reflects a significant step forward in the efficient production of biologically important peptides, demonstrating his commitment to innovation and collaboration in scientific research.